1. O-GlcNAcylation in women’s cancers: breast, endometrial and ovarian
   Gloria M. Trinca et al, 2017, J Bioenerg Biomembr CrossRef
2. Checkpoint kinase 1–induced phosphorylation ofO-linked β-N-acetylglucosamine transferase regulates the intermediate filament network during cytokinesis
   Zhe Li et al, 2017, J. Biol. Chem. CrossRef
3. Simulated microgravity inhibits cell focal adhesions leading to reduced melanoma cell proliferation and metastasis via FAK/RhoA-regulated mTORC1 and AMPK pathways
   Xin Tan et al, 2018, Sci Rep CrossRef
4. O -Glycosylation with O -linked β- N -acetylglucosamine increases vascular contraction: Possible modulatory role on Interleukin-10 signaling pathway
   Jéssica S.G. Miguez et al, 2018, Life Sciences CrossRef
5. Quercetin induces cell death in cervical cancer by reducing O-GlcNAcylation of adenosine monophosphate-activated protein kinase
   Akhtar Ali et al, 2018, Anat Cell Biol CrossRef
6. The O-GlcNAc Modification on Kinases.
   Paul A Schwein et al, 2020, ACS Chem Biol CrossRef
7. Quantitative proteomic analysis of the association between decreasing O‑GlcNAcylation and metastasis in MCF‑7 breast cancer cells
   Pukkavadee Netsirisawan et al, 2020, Int J Oncol CrossRef
8. MicroRNA-7-5p′s role in the O-GlcNAcylation and cancer metabolism
   Sin Yung Woo et al, 2020, Non-coding RNA Research CrossRef
9. The hexosamine biosynthetic pathway and cancer: Current knowledge and future therapeutic strategies
   Christine Lam et al, 2021, Cancer Letters CrossRef
10. Role of Hexosamine Biosynthetic Pathway on Cancer Stem Cells: Connecting Nutrient Sensing to Cancer Cell Plasticity
    Giang Le Minh et al, 2021 CrossRef
11. A living cell-based fluorescent reporter for high-throughput screening of anti-tumor drugs
    Ningning Tang et al, 2021, Journal of Pharmaceutical Analysis CrossRef
12. Targeted Inhibition of O-Linked β-N-Acetylglucosamine Transferase as a Promising Therapeutic Strategy to Restore Chemosensitivity and Attenuate Aggressive Tumor Traits in Chemoresistant Urothelial Carcinoma of the Bladder
    Hye Won Lee et al, 2022, Biomedicines CrossRef
13. Blocking ATM Attenuates SKOV3 Cell Proliferation and Migration by Disturbing OGT/OGA Expression via hsa-miR-542-5p
    Ning Wang et al, 2022, Front. Oncol. CrossRef
14. O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy
    Qingsong Lu et al, 2022, Mol Med CrossRef
15. Relationship Between O-GlcNAcase Expression and Prognosis of Patients With Osteosarcoma
    Thamonwan Sombutthaweesri et al, 2022 CrossRef
16. O-GlcNAcylation in cancer development and immunotherapy
    Xue-Fen He et al, 2023, Cancer Letters CrossRef
17. The O-GlcNAc dichotomy: when does adaptation become pathological?
    Tiago J. Costa et al, 2023 CrossRef
18. Role of O-GlcNAcylation in Cancer Biology
    Yuxuan Li et al, 2023, Pathology - Research and Practice CrossRef
19. FOXL2 regulates RhoA expression to change actin cytoskeleton rearrangement in granulosa cells of chicken pre-ovulatory follicles
    Xuelian Li et al, 2024 CrossRef
20. The Mechanism of Total Ginseng Extracts in the Treatment of Lung Cancer Progression Based on Network Pharmacology and Experimental Validation
    Hong-Kuan Hana et al, 2023 CrossRef
21. O-GlcNAcylation: Crosstalk between Hemostasis, Inflammation, and Cancer
    Itzel Patricia Vásquez Martínez et al, 2024, IJMS CrossRef
22. Metabolomic Analysis of Histological Composition Variability of High-Grade Serous Ovarian Cancer Using 1H HR MAS NMR Spectroscopy
    Agnieszka Skorupa et al, 2024, IJMS CrossRef
23. Glycan diversity in ovarian cancer: Unraveling the immune interplay and therapeutic prospects
    Gerrit Wolters-Eisfeld et al, 2024, Semin Immunopathol CrossRef
24. Opportunities for Therapeutic Modulation of O-GlcNAc
    Steven S. Cheng et al, 2024, Chem. Rev. CrossRef
25. O-GlcNAcylation in ovarian tumorigenesis and its therapeutic implications
    Lu Xia et al, 2025, Translational Oncology CrossRef